Please confirm that you would like to log out of Medscape.
If you log out, you will be required to enter your username and password the next time you visit.
Log outCancel
APA 2019Experts Go Toe-to-Toe Over Esketamine Depression StudyThe ongoing debate over the risks and benefits of recently approved esketamine nasal spray for treatment-resistant depression spilled over into a heated discussion at the APA 2019 Annual Meeting.
Medscape Medical News, May 21, 2019
APA 2019CBD Gel Promising for Fragile X SyndromeA clear transdermal cannabidiol (CBD) gel improved emotional and behavioral symptoms in children and adolescents with fragile X syndrome and was well tolerated in a phase 2 study.
Genetic Test Identifies Best AntidepressantPatients with treatment-resistant depression were more likely to achieve remission when their medication selection was guided
by a novel psychotropic genetic test.
